NO301174B1 - Fremgangsmåte for fremstilling av en forbedret terapeutisk aktiv vevsplasminogenaktivator - Google Patents
Fremgangsmåte for fremstilling av en forbedret terapeutisk aktiv vevsplasminogenaktivator Download PDFInfo
- Publication number
- NO301174B1 NO301174B1 NO901920A NO901920A NO301174B1 NO 301174 B1 NO301174 B1 NO 301174B1 NO 901920 A NO901920 A NO 901920A NO 901920 A NO901920 A NO 901920A NO 301174 B1 NO301174 B1 NO 301174B1
- Authority
- NO
- Norway
- Prior art keywords
- plasminogen activator
- denotes
- tissue plasminogen
- improved
- ability
- Prior art date
Links
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 title claims 3
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 title claims 3
- 229960000187 tissue plasminogen activator Drugs 0.000 title claims 3
- 238000004519 manufacturing process Methods 0.000 title claims 2
- 108050006955 Tissue-type plasminogen activator Proteins 0.000 claims 4
- 229950003499 fibrin Drugs 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 108090000623 proteins and genes Proteins 0.000 claims 3
- 102000009123 Fibrin Human genes 0.000 claims 2
- 108010073385 Fibrin Proteins 0.000 claims 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 101000801481 Homo sapiens Tissue-type plasminogen activator Proteins 0.000 claims 1
- 102000000589 Interleukin-1 Human genes 0.000 claims 1
- 108010002352 Interleukin-1 Proteins 0.000 claims 1
- 102000001938 Plasminogen Activators Human genes 0.000 claims 1
- 108010001014 Plasminogen Activators Proteins 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 150000007513 acids Chemical class 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 210000004978 chinese hamster ovary cell Anatomy 0.000 claims 1
- 230000003480 fibrinolytic effect Effects 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 102000047823 human PLAT Human genes 0.000 claims 1
- 229940127126 plasminogen activator Drugs 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- 238000013518 transcription Methods 0.000 claims 1
- 230000035897 transcription Effects 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
- C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Graft Or Block Polymers (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- External Artificial Organs (AREA)
- Pens And Brushes (AREA)
- Fixed Capacitors And Capacitor Manufacturing Machines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP27477087 | 1987-10-29 | ||
| JP32078587 | 1987-12-18 | ||
| JP7012688 | 1988-03-23 | ||
| JP18935188 | 1988-07-27 | ||
| PCT/JP1988/001098 WO1989003874A1 (en) | 1987-10-29 | 1988-10-28 | Novel polypeptide compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO901920L NO901920L (no) | 1990-04-27 |
| NO901920D0 NO901920D0 (no) | 1990-04-27 |
| NO301174B1 true NO301174B1 (no) | 1997-09-22 |
Family
ID=27465213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO901920A NO301174B1 (no) | 1987-10-29 | 1990-04-27 | Fremgangsmåte for fremstilling av en forbedret terapeutisk aktiv vevsplasminogenaktivator |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US5556621A (fi) |
| JP (1) | JP2534332B2 (fi) |
| KR (1) | KR970005046B1 (fi) |
| AT (1) | ATE125294T1 (fi) |
| DE (1) | DE3854195T2 (fi) |
| DK (1) | DK104390A (fi) |
| FI (1) | FI102844B1 (fi) |
| HU (2) | HU217100B (fi) |
| NO (1) | NO301174B1 (fi) |
| WO (1) | WO1989003874A1 (fi) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2007364A1 (en) * | 1989-01-17 | 1990-07-17 | David J. Livingston | Gene sequences encoding modified residues situated in the protease domain of tpa |
| CA2278823A1 (en) | 1997-01-29 | 1998-07-30 | Joe M. Mccord | Plasminogen activator as an anti-inflammatory agent |
| KR100613531B1 (ko) | 1997-09-22 | 2006-08-16 | 도시오 미야타 | 멕신 단백질 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4753879A (en) * | 1984-08-27 | 1988-06-28 | Biogen N.V. | Modified tissue plasminogen activators |
| US5073494A (en) * | 1985-04-22 | 1991-12-17 | Genentech, Inc. | Human tissue plasminogen activator substituted at position 275 or at positions 275 and 277 |
| EP0199574B1 (en) * | 1985-04-22 | 1991-10-23 | Genentech, Inc. | Human tissue plasminogen activator mutants, methods and intermediates therefor, and compositions using such mutants |
| NZ217331A (en) * | 1985-08-26 | 1989-05-29 | Lilly Co Eli | Tissue plasminogen activator derivatives and genetically engineered product |
| KR880700856A (ko) * | 1985-12-20 | 1988-04-12 | 로버어트 에이 아미테이지 | 조직 플라스미노겐 활성화인자(tpa)상사체 |
| DK43387A (da) * | 1986-01-29 | 1987-07-30 | Beecham Group Plc | Fibrinolytisk enzym |
| PT84588B (en) * | 1986-04-02 | 1989-05-09 | Beecham Group Plc | Process for preparing a fibrinolytic enzyme |
| DE3886755T3 (de) * | 1987-06-30 | 2005-12-08 | Genentech, Inc., South San Francisco | Verfahren zur behandlung von gefässkrankheiten. |
| US4935237A (en) * | 1988-03-21 | 1990-06-19 | Genentech, Inc. | Processes for the preparation of t-PA mutants |
| US5094953A (en) * | 1988-03-21 | 1992-03-10 | Genentech, Inc. | Human tissue plasminogen activator variants |
| US5037646A (en) * | 1988-04-29 | 1991-08-06 | Genentech, Inc. | Processes for the treatment of vascular disease |
| JP2793462B2 (ja) * | 1993-02-23 | 1998-09-03 | 山陽特殊製鋼株式会社 | 超耐食Ｎｉ基合金 |
-
1988
- 1988-10-28 HU HU886304A patent/HU217100B/hu not_active IP Right Cessation
- 1988-10-28 DE DE3854195T patent/DE3854195T2/de not_active Expired - Lifetime
- 1988-10-28 WO PCT/JP1988/001098 patent/WO1989003874A1/ja active IP Right Grant
- 1988-10-28 JP JP63272020A patent/JP2534332B2/ja not_active Expired - Lifetime
- 1988-10-28 KR KR1019890701197A patent/KR970005046B1/ko not_active IP Right Cessation
- 1988-10-28 AT AT88909384T patent/ATE125294T1/de not_active IP Right Cessation
-
1990
- 1990-04-25 FI FI902066A patent/FI102844B1/fi not_active IP Right Cessation
- 1990-04-27 DK DK104390A patent/DK104390A/da not_active Application Discontinuation
- 1990-04-27 NO NO901920A patent/NO301174B1/no not_active IP Right Cessation
-
1994
- 1994-05-04 US US08/237,249 patent/US5556621A/en not_active Expired - Fee Related
-
1995
- 1995-06-30 HU HU95P/P00671P patent/HU211335A9/hu unknown
-
1996
- 1996-09-10 US US08/712,999 patent/US5739012A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE3854195T2 (de) | 1995-12-21 |
| JP2534332B2 (ja) | 1996-09-11 |
| WO1989003874A1 (en) | 1989-05-05 |
| DK104390D0 (da) | 1990-04-27 |
| US5739012A (en) | 1998-04-14 |
| HU211335A9 (en) | 1995-11-28 |
| KR890701732A (ko) | 1989-12-21 |
| NO901920L (no) | 1990-04-27 |
| HUT58811A (en) | 1992-03-30 |
| HU217100B (hu) | 1999-11-29 |
| ATE125294T1 (de) | 1995-08-15 |
| DE3854195D1 (de) | 1995-08-24 |
| HU886304D0 (en) | 1991-11-28 |
| KR970005046B1 (ko) | 1997-04-11 |
| FI102844B (fi) | 1999-02-26 |
| NO901920D0 (no) | 1990-04-27 |
| JPH02167076A (ja) | 1990-06-27 |
| FI902066A0 (fi) | 1990-04-25 |
| US5556621A (en) | 1996-09-17 |
| DK104390A (da) | 1990-06-21 |
| FI102844B1 (fi) | 1999-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU615663B2 (en) | A method for recovering a purified animal growth hormone or an anolog thereof | |
| EP0035384B1 (en) | Deoxynucleotide linkers to be attached to a cloned dna coding sequence | |
| US4769326A (en) | Expression linkers | |
| NO174351C (no) | Fremgangsmåte for fremstilling av human insulinforlöper samt DNA-sekvens og vektor til anvendelse av fremgangsmåten | |
| ATE282093T1 (de) | Verfahren zur herstellung von proteinprodukten in aspergillus-oryzae und in aspergillus zu verwendender promotor | |
| KR840001837A (ko) | 인체의 면역성 인터페론의 제조방법 | |
| IL94128A (en) | Nucleic acids encoding vascular endothelial cell growth factors, expression vectors and host cells comprising such nucleic acids and methods of producing such vascular endothelial growth factors | |
| CA2206399A1 (en) | Method for secreting thrombopoietin polypeptides | |
| EP0489711A3 (en) | Method for producing human growth hormone | |
| DK164940C (da) | Polypeptid med human-gamma-interferonaktivitet, genteknologisk fremgangsmaade til fremstilling deraf, hybrid-plasmider indeholdende en dna-sekvens, der koder for peptidet, vaertsorganismer indeholdende hybridplasmiderne, samt laegemidler, som indeholder polypeptidet | |
| AU2682388A (en) | Diagnostic system | |
| KR880009991A (ko) | 항혈액응고작용을 갖는 폴리펩티드 | |
| NO301174B1 (no) | Fremgangsmåte for fremstilling av en forbedret terapeutisk aktiv vevsplasminogenaktivator | |
| ES2013500A6 (es) | Metodo para producir una variante de secuencioa de aminoacidos de un activador de plasmionogeno. | |
| JPS62278986A (ja) | ハイブリツドポリペプチド | |
| EP0232107A3 (en) | Human lymphotoxin polypeptide derivative | |
| IE892412L (en) | Human protein C mutants and method for preparing the same | |
| EP0259891A2 (en) | [Leu 13] motilin, DNAs coding for same and methods for producing same | |
| EP0330700A4 (en) | Human prourokinase-like polypeptide. | |
| JPH1175876A (ja) | 新規な微生物トランスグルタミナーゼの製造法 | |
| GR3026465T3 (en) | Biosynthetic process for the preparation of proteins. | |
| JP3100145B2 (ja) | 分裂酵母シゾサッカロミセス・ポンベにおけるタンパク質合成のための発現ベクター | |
| EP0300459A3 (en) | Human pancreatic secretory trypsin inhibitor | |
| KR910001046A (ko) | 비융합 단백질을 제조하기 위한 미생물내 발현용 발현벡터 | |
| EP0276778A3 (en) | High level expression in e. coli of soluble mature hil-1beta and derivatives with altered biological activity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |